Advertisement

Topics

Financial Contrast: Arena Pharmaceuticals

03:50 EST 24 Nov 2017 | Topix

Arena Pharmaceuticals and Sunesis Pharmaceuticals are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership. Arena Pharmaceuticals has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500.

Original Article: Financial Contrast: Arena Pharmaceuticals

NEXT ARTICLE

More From BioPortfolio on "Financial Contrast: Arena Pharmaceuticals"

Quick Search
Advertisement